BRIEF published on 11/12/2024 at 13:05, 8 days 23 hours ago Yunu nomme Patrick McNamara pour accélérer sa croissance Yunu Développement Des Affaires Sciences De La Vie Patrick McNamara Imagerie D'essais Cliniques
BRIEF published on 11/12/2024 at 13:05, 8 days 23 hours ago Yunu Appoints Patrick McNamara to Accelerate Growth Business Development Life Sciences Yunu Clinical Trial Imaging Patrick McNamara
PRESS RELEASE published on 11/12/2024 at 13:00, 8 days 23 hours ago Yunu Welcomes Veteran Life Sciences Commercial Leader Patrick McNamara Yunu appoints Patrick McNamara as Senior VP of Business Development to drive growth initiatives in life sciences sector with expertise in clinical trial imaging workflow and data management solutions Business Development Life Sciences Yunu Clinical Trial Imaging Patrick McNamara
BRIEF published on 09/12/2024 at 13:05, 2 months 8 days ago Yunu étend l'utilisation gratuite de la plateforme du centre de cancérologie pour tous les essais cliniques du groupe d'oncologie pédiatrique Yunu Recherche Clinique Technologie D'imagerie Essais Cliniques Du COG Cancer Pédiatrique
BRIEF published on 09/12/2024 at 13:05, 2 months 8 days ago Yunu Extends Free Cancer Center Use of Platform for All Children's Oncology Group Clinical Trials Clinical Research Imaging Technology Yunu COG Clinical Trials Pediatric Cancer
PRESS RELEASE published on 09/12/2024 at 13:00, 2 months 8 days ago Yunu Extends Free Cancer Center Use of Platform for All Children’s Oncology Group Clinical Trials Yunu extends free platform use for Children's Oncology Group (COG) trials nationwide, providing world-class imaging capabilities and transforming pediatric cancer care Clinical Trials Yunu Imaging Workflow Pediatric Cancer Children's Oncology Group
BRIEF published on 07/23/2024 at 13:05, 3 months 28 days ago Taux d'erreur d'imagerie de 50 % dans les essais cliniques discutés par des panélistes d'experts de 5 centres de cancérologie désignés par le NCI Essais Cliniques Recherche Médicale Oncologie Erreurs D'imagerie Plateforme Yunu
BRIEF published on 07/23/2024 at 13:05, 3 months 28 days ago 50% Imaging Error Rate in Clinical Trials Discussed by Expert Panelists from 5 NCI-Designated Cancer Centers Clinical Trials Oncology Medical Research Imaging Errors Yunu Platform
PRESS RELEASE published on 07/23/2024 at 13:00, 3 months 28 days ago 50% Imaging Error Rate in Clinical Trials Discussed by Expert Panelists from 5 NCI-Designated Cancer Centers Panel at AACI-CRI symposium highlights concerning imaging accuracy crisis in clinical trials. Yunu's platform addresses issues, leading to significant workflow efficiencies Clinical Trials Yunu Imaging Accuracy Workflow Efficiencies AACI-CRI Symposium
BRIEF published on 05/08/2024 at 13:05, 6 months 12 days ago Yunu Introduces Advanced Imaging Workflow for Investigator-Initiated Trials Data Management Yunu Clinical Trial Imaging Cloud-based Platform Investigator-initiated Trials
Published on 11/21/2024 at 12:00, 36 minutes ago Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 36 minutes ago Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 6 minutes ago FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 2 hours 33 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 2 hours 36 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 12:15, 21 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 11:30, 1 hour 6 minutes ago APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 11:01, 1 hour 34 minutes ago Original-Research: SMT Scharf AG (von Montega AG): Kaufen
Published on 11/21/2024 at 06:58, 5 hours 38 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 38 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 5 hours 38 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 16 hours 28 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 16 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
